• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

February 8, 2022

FDA Approves Fleqsuvy for Treatment of Spasticity Related to Multiple Sclerosis

Author(s):

Ashley Gallagher, Editor

The agency has also approved the baclofen oral suspension for Azurity Pharmaceuticals to treat individuals with other spinal cord diseases or injuries.

The FDA has approved baclofen oral suspension (Fleqsuvy, Azurity Pharmaceuticals) at the 25-mg-per-5-mL strength for the treatment of individuals with spasticity from multiple sclerosis (MS) or individuals with other spinal cord diseases or injuries.1

"The approval of Fleqsuvy represents our commitment to providing innovative alternative formulations that address individualized patient needs. The clinical profile of Fleqsuvy allows for a tailored and flexible approach to dosing for patients suffering from spasticity, a debilitating symptom that may impact daily functioning," Amit Patel, chairman and CEO of specialty pharmaceutical company Azurity Pharmaceuticals, said in a statement.1

Nearly 1 million individuals have MS in the United States. Spasticity is a commonly reported symptom for MS. Because of the severity of spasticity resulting from MS or patients with other spinal cord diseases or injuries, dosing becomes paramount to providing appropriate relief.1

In addition, dysphagia is commonly experienced with MS. Fleqsuvy provides an option as a baclofen oral liquid medication at an effective dose for patients who have trouble swallowing pills or prefer a liquid formulation. As the most concentrated FDA-approved oral liquid baclofen formulation, Fleqsuvy allows for the lowest volume to be prescribed for patients, which can be an important consideration for those suffering from dysphagia.1

Fleqsuvy is a grape-flavored oral suspension formulation, particularly for the relief of clonus, flexor spasms and concomitant pain, and muscular rigidity. It is available in bottles of either 120 or 300 mL.1

Fleqsuvy is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders, according to the statement.

A spinal cord injury occurs when there is damage to a bundle of cells and nerves that sends and receives signals from the brain and the rest of the body, according to the National Institutes of Health (NIH).2

Spinal cord injuries can result in either permanent or temporary changes in movement, sensation, strength, and bodily functions below the site of injury. The most common causes of spinal cord injuries in the United States are catastrophic falls and motor vehicle accidents.2

Injuries with little or no cell death can result in an almost complete recovery.2

However, injuries that occur higher on the spinal cord are often more serious and can cause paralysis in the body, according to the NHI.2

Reference

1. Azurity Pharmaceuticals, INC announces FDA approval of Fleqsuvy (baclofen oral suspension). PR Newswire. News release. February 7, 2022. Accessed February 7, 2022. Email.

2. National Institute of Neurological Disorders and Stroke. Spinal cord injury information page. Updated June 4, 2021. Accessed February 7, 2022. https://www.ninds.nih.gov/Disorders/All-Disorders/Spinal-Cord-Injury-Information-Page

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit:  Artur | stock.adobe.com
Related Content
Advertisement
elbow bones injury - Image credit: SoftSheep | stock.adobe.com
July 15th 2025

Type 2 Diabetes and Obesity in Teens Could Increase Risk of Osteoporosis

Kennedy Ferruggia, Assistant Editor
COBRRA Trial Results Raise Questions About VTE Management
July 15th 2025

COBRRA Trial Results Raise Questions About VTE Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Insulin and syringe | Image Credit: © Sherry Young - stock.adobe.com
July 15th 2025

Insulin Aspart-xjhz Becomes First Interchangeable Biosimilar Rapid-Acting Insulin

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Health care professional preparing a vaccine -- Image credit: REDPIXEL | stock.adobe.com
July 15th 2025

Study: Recommendations From Health Care Professionals Improve Immunization Rates Among Patients With CKD

Gillian McGovern, Associate Editor
Respiratory Virus Genetic Material Micrograph - Image credit: GOLVR | stock.adobe.com
July 15th 2025

Targeting the Integrated Stress Response Through a Platform for Antiviral Drug Discovery Against Zika, Herpes, and RSV

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
elbow bones injury - Image credit: SoftSheep | stock.adobe.com
July 15th 2025

Type 2 Diabetes and Obesity in Teens Could Increase Risk of Osteoporosis

Kennedy Ferruggia, Assistant Editor
COBRRA Trial Results Raise Questions About VTE Management
July 15th 2025

COBRRA Trial Results Raise Questions About VTE Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Insulin and syringe | Image Credit: © Sherry Young - stock.adobe.com
July 15th 2025

Insulin Aspart-xjhz Becomes First Interchangeable Biosimilar Rapid-Acting Insulin

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Health care professional preparing a vaccine -- Image credit: REDPIXEL | stock.adobe.com
July 15th 2025

Study: Recommendations From Health Care Professionals Improve Immunization Rates Among Patients With CKD

Gillian McGovern, Associate Editor
Respiratory Virus Genetic Material Micrograph - Image credit: GOLVR | stock.adobe.com
July 15th 2025

Targeting the Integrated Stress Response Through a Platform for Antiviral Drug Discovery Against Zika, Herpes, and RSV

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.